OMB control number

[ATSDR] Evaluating the Association between Serum Concentrations of Per- and Polyfluoroalkyl Substances (PFAS) and Symptoms and Diagnoses of Selected Acute Viral Illnesses

OMB 0923-0064 · HHS/TSDR.

OMB 0923-0064
Latest Forms, Documents, and Supporting Material
Document
Name
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Justification for No Material/Nonsubstantive Change
1 - 2 SSB_PFAS and Viral Infections_20220729.docx (document unavailable)
Supporting Statement B
1 - 1 SSA_PFAS Viral Infections_20220729.docx (document unavailable)
Supporting Statement A
1 - 3 List of Attachments_20220729.docx (document unavailable)
Supplementary Document
Protocol_PFAS Viral Infections_20220729.docx (document unavailable)
Supplementary Document
Supplementary Document
P_ApndxK_PrivacyActStmnt_11092021.docx (document unavailable)
Supplementary Document
P_ApndxJ_ChldAssntCopy.docx (document unavailable)
Supplementary Document
Supplementary Document
Supplementary Document
P_ApndxG2_RcrtmntCmms.docx (document unavailable)
Supplementary Document
P_ApndxG1_PEATTCoverLttr_20220729.docx (document unavailable)
Supplementary Document
P_ApndxG_RcrtmntLttr.docx (document unavailable)
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
1 - AttD_IRB approval.docx (document unavailable)
Supplementary Document
AttC_PIA CPO signed.pdf (document unavailable)
Supplementary Document
1 - AttB1_60D PblcCmmntsAgncyRespns.docx (document unavailable)
Supplementary Document
1 - AttB_60D FRN PFAS Viral Infection.pdf (document unavailable)
Supplementary Document
Supplementary Document